VCM
GILD icon

Virtue Capital Management’s Gilead Sciences GILD Stock Holding History

Virtue Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$352K Sell
2,794
-134
-5% -$17.7K 0.05% 249
2026
Q1 		$399K Buy
2,928
+954
+48% +$134K 0.06% 219
2025
Q4 		$240K Buy
+1,974
New +$240K 0.04% 271
2024
Q1 		– Sell
-5,362
Closed -$448K – 400
2023
Q4 		$448K Sell
5,362
-2,667
-33% -$208K 0.09% 219
2023
Q3 		$620K Hold
8,029
– – 0.11% 186
2023
Q2 		$620K Buy
8,029
+1,470
+22% +$117K 0.11% 186
2023
Q1 		$549K Sell
6,559
-1,462
-18% -$121K 0.09% 201
2022
Q4 		$689K Buy
+8,021
New +$635K 0.11% 135
2022
Q3 		– Sell
-4,533
Closed -$280K – 276
2022
Q2 		$280K Sell
4,533
-2,582
-36% -$160K 0.04% 198
2022
Q1 		$423K Sell
7,115
-3,554
-33% -$227K 0.07% 295
2021
Q4 		$775K Buy
10,669
+1,643
+18% +$113K 0.11% 206
2021
Q3 		$630K Sell
9,026
-714
-7% -$50.2K 0.11% 214
2021
Q2 		$671K Sell
9,740
-2,270
-19% -$152K 0.13% 200
2021
Q1 		$776K Buy
12,010
+520
+5% +$33.5K 0.18% 163
2020
Q4 		$669K Sell
11,490
-2,290
-17% -$138K 0.16% 169
2020
Q3 		$871K Sell
13,780
-3,038
-18% -$211K 0.21% 137
2020
Q2 		$1.29M Buy
+16,818
New +$1.29M 0.3% 98
2020
Q1 		– Sell
-8,921
Closed -$580K – 100
2019
Q4 		$580K Sell
8,921
-4,381
-33% -$285K 0.17% 120
2019
Q3 		$843K Sell
13,302
-1,878
-12% -$123K 0.28% 113
2019
Q2 		$1.03M Buy
+15,180
New +$999K 0.37% 87
2018
Q4 		– Sell
-30,086
Closed -$2.32M – 145
2018
Q3 		$2.32M Buy
30,086
+14,982
+99% +$1.13M 0.49% 57
2018
Q2 		$1.07M Buy
15,104
+2,255
+18% +$159K 0.52% 55
2018
Q1 		$951K Buy
12,849
+1,012
+9% +$80.4K 0.5% 54
2017
Q4 		$848K Buy
+11,837
New +$899K 0.48% 29

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Virtue Capital Management's GILD Position: Q2 2026 in Review

Virtue Capital Management reduced its Gilead Sciences (GILD) stake by 4.6% in Q2 2026, selling an estimated $17.7K and leaving 2,794 shares worth $352K. The position accounts for 0.05% of the portfolio, ranked #249.

Virtue Capital Management first reported a position in GILD in Q4 2017 and has held it in 24 quarters since. The position peaked at $2.32M in Q3 2018. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Virtue Capital Management held 2,794 shares of Gilead Sciences worth $352K as of Q2 2026.
  • Virtue Capital Management sold 134 Gilead Sciences shares in Q2 2026, an estimated $17.7K.
  • Gilead Sciences made up 0.05% of Virtue Capital Management's portfolio in Q2 2026, its #249 holding.
  • Virtue Capital Management first reported a position in Gilead Sciences in Q4 2017 and has held it in 24 quarters since.
  • Virtue Capital Management's Gilead Sciences position peaked at $2.32M in Q3 2018.
  • 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Virtue Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.